We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRX icon
376
PUT
Xerox
XRX
$427M
$552K 0.01%
248,800
– –
ORTX
377
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$551K 0.01%
71,010
– –
ZTO icon
378
ZTO Express
ZTO
$17.8B
$544K 0.01%
22,490
-6,310
-22% -$161K
EPRT icon
379
Essential Properties Realty Trust
EPRT
$6.63B
$541K 0.01%
+25,000
New +$596K
LCA
380
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$528K 0.01%
50,644
– –
CCI icon
381
Crown Castle
CCI
$32.2B
$525K 0.01%
5,700
-73,638
-93% -$7.63M
ORCL icon
382
Oracle
ORCL
$416B
$522K 0.01%
4,926
+2,933
+147% +$339K
PCVX icon
383
Vaxcyte
PCVX
$8.79B
$510K 0.01%
+10,000
New +$493K
ICLR icon
384
Icon
ICLR
$12.6B
$504K 0.01%
2,045
-4,100
-67% -$1.03M
KLRS
385
Kalaris Therapeutics
KLRS
$101M
$495K 0.01%
10,000
+2,609
+35% +$178K
THRX
386
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$488K 0.01%
181,452
+60,000
+49% +$235K
NERV icon
387
Minerva Neurosciences
NERV
$209M
$483K 0.01%
+70,000
New +$627K
SNOW icon
388
Snowflake
SNOW
$113B
$473K 0.01%
3,098
-5,707
-65% -$929K
CNTB
389
Connect Biopharma Holdings
CNTB
$138M
$469K 0.01%
603,900
– –
HROW icon
390
Harrow
HROW
$1.52B
$467K 0.01%
+32,508
New +$568K
AGNC icon
391
AGNC Investment
AGNC
$12.9B
$467K 0.01%
49,419
-15,962
-24% -$158K
ACRS icon
392
Aclaris Therapeutics
ACRS
$851M
$466K 0.01%
68,014
-5,000
-7% -$42.7K
DTIL icon
393
Precision BioSciences
DTIL
$208M
$456K 0.01%
44,610
– –
CNTX icon
394
Context Therapeutics
CNTX
$47.1M
$447K 0.01%
295,700
+230,072
+351% +$260K
BNTX icon
395
BioNTech
BNTX
$23.3B
$435K 0.01%
+4,000
New +$442K
UBX
396
DELISTED
Unity Biotechnology
UBX
$430K 0.01%
179,080
– –
SONO icon
397
Sonos
SONO
$1.86B
$420K 0.01%
+32,500
New +$482K
NAMS icon
398
NewAmsterdam Pharma
NAMS
$3.34B
$416K 0.01%
+45,000
New +$487K
GLUE icon
399
Monte Rosa Therapeutics
GLUE
$1.34B
$409K 0.01%
85,478
-15,000
-15% -$96.6K
EDR
400
DELISTED
Endeavor Group Holdings, Inc.
EDR
$398K 0.01%
+20,000
New +$459K
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.